First Time Loading...
S

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505

Watchlist Manager
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
Watchlist
Price: 7.73 CNY 0.39% Market Closed
Updated: May 5, 2024

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SSE:688505
Operating Income
¥102.3m
CAGR 3-Years
-12%
CAGR 5-Years
2%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥3.7B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.3B
CAGR 3-Years
22%
CAGR 5-Years
22%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥3.6B
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
10%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.7B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
6%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Operating Income
¥787.7m
CAGR 3-Years
32%
CAGR 5-Years
24%
CAGR 10-Years
N/A

See Also

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Operating Income?
Operating Income
102.3m CNY

Based on the financial report for Dec 31, 2023, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Operating Income amounts to 102.3m CNY.

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
2%

Over the last year, the Operating Income growth was -18%. The average annual Operating Income growth rates for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd have been -12% over the past three years , 2% over the past five years .